At the same time, compared with the diagnostic efficiency of tumor markers alone, UBE2C combined with clinical markers has higher diagnostic efficiency, which reduces the misdiagnosis and missed diagnosis rate of patients to a certain extent. This evidence concerns the gene UBE2C and neoplasm.